WallStSmart
SEER

Seer Inc

NASDAQ: SEER · HEALTHCARE · BIOTECHNOLOGY

$1.82
-3.24% today

Updated 2026-06-05

Market cap
$102.82M
P/E ratio
P/S ratio
6.20x
EPS (TTM)
$-1.24
Dividend yield
52W range
$2 – $2
Volume
0.4M

Seer Inc (SEER) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20182019202020212022202320242025
Operating cash flow$-4.65M$-13.07M$-20.83M$-46.35M$-60.78M$-59.06M$-46.11M$-44.45M
Capital expenditures$168000.00$4.13M$4.53M$6.92M$10.27M$7.31M$3.58M$1.80M
Depreciation
Stock-based comp$672000.00$1.56M$7.35M$25.93M$33.67M$34.42M$28.21M$15.41M
Free cash flow$-4.82M$-17.20M$-25.36M$-53.27M$-71.05M$-66.37M$-49.69M$-46.24M
Investing cash flow
Financing cash flow
Dividends paid$72.34M
Share repurchases
Debt repayment
Net change in cash$-100.59M$-179.60M

Frequently asked questions

What is Seer Inc's revenue?

Seer Inc's trailing twelve-month revenue is $16.58M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is SEER?

In its most recent fiscal year, SEER ran a gross margin of 11.80%, an operating margin of -486.70%, and a net margin of -456.60%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does SEER generate?

SEER produced $-46.24M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is SEER's balance sheet healthy?

SEER holds $47.28M in cash and equivalents against — in long-term debt, on $259.31M of shareholder equity. That debt is best read against the cash flow the business throws off each year.